TickerFacts.

A business in context

VKTX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-23 · 0001193125-26-405580 · Items 1.01,2.03,9.01

  2. 8-K · Current report

    Report date 2026-09-22 · 0001193125-26-397219 · Items 8.01,9.01

  3. 4 · Ownership change

    Report date 2026-08-01 · 0002144542-26-000004

  4. 4 · Ownership change

    Report date 2026-07-28 · 0001193125-26-324448

  5. 4 · Ownership change

    Report date 2026-07-28 · 0001193125-26-324447

  6. 4 · Ownership change

    Report date 2026-07-28 · 0001193125-26-324446

  7. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-324219

  8. 8-K · Current report

    Report date 2026-07-29 · 0001193125-26-323652 · Items 2.02,9.01

  9. 4 · Ownership change

    Report date 2026-06-01 · 0001193125-26-256039

  10. 8-K · Current report

    Report date 2026-05-19 · 0001193125-26-239535 · Items 5.07,9.01

  11. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-193315

  12. 8-K · Current report

    Report date 2026-04-29 · 0001193125-26-191487 · Items 2.02,9.01

  13. DEF 14A · Proxy statement

    Report date 2026-05-19 · 0001193125-26-137915

  14. 4 · Ownership change

    Report date 2026-03-10 · 0001193125-26-100581

  15. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-046876

  16. 8-K · Current report

    Report date 2026-02-11 · 0001193125-26-046536 · Items 2.02,9.01

  17. 4 · Ownership change

    Report date 2026-01-12 · 0001193125-26-023030

  18. 4 · Ownership change

    Report date 2026-01-02 · 0001193125-26-003116

  19. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-247059

  20. 8-K · Current report

    Report date 2025-10-22 · 0001193125-25-246775 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2025-08-19 · 0001607678-25-000003 · Items 7.01,9.01

  22. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-097950

  23. 8-K · Current report

    Report date 2025-07-23 · 0000950170-25-097885 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-05-20 · 0000950170-25-077865 · Items 5.07,9.01

  25. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-058129

  26. 8-K · Current report

    Report date 2025-04-23 · 0000950170-25-057337 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-04-18 · 0000950170-25-057323 · Items 4.01,8.01,9.01

  28. DEF 14A · Proxy statement

    Report date 2025-05-20 · 0000950170-25-052162

  29. 8-K · Current report

    Report date 2025-03-10 · 0000950170-25-036820 · Items 1.01,2.03,8.01,9.01

  30. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-027824

  31. 8-K · Current report

    Report date 2025-02-05 · 0000950170-25-014464 · Items 2.02,9.01

  32. SC 13G/A · Ownership disclosure

    0000905148-24-003164

  33. SC 13G/A · Ownership disclosure

    0000932471-24-001267

  34. 8-K · Current report

    Report date 2024-11-04 · 0000950170-24-120267 · Items 7.01,9.01

  35. SC 13G/A · Ownership disclosure

    0000932471-24-000703

  36. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-116708

  37. 8-K · Current report

    Report date 2024-10-23 · 0000950170-24-116642 · Items 2.02,9.01

  38. SC 13G/A · Ownership disclosure

    0000093751-24-000891

  39. SC 13G/A · Ownership disclosure

    0001086364-24-008371

  40. 10-Q · Quarterly report

    Report date 2024-06-30 · 0000950170-24-086111

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 3 transaction rows3SGrant / award: 5 transaction rows5AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

8 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-01
2026-08-07
Kelly-Gemmell Dorothy ElizabethA · Grant / award
Acquired
Common Stock, par value $0.00001 per share6333.00.0
2026-08-01
2026-08-07
Kelly-Gemmell Dorothy ElizabethA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
40800.00.0
2026-07-29
2026-07-29
Lian BrianS · Sale
Disposed
Common Stock, par value $0.00001 per share148517.033.32
2026-07-29
2026-07-29
ZANTE GREGS · Sale
Disposed
Common Stock, par value $0.00001 per share21217.033.47
2026-07-29
2026-07-29
Mancini MariannaS · Sale
Disposed
Common Stock, par value $0.00001 per share18217.033.47
2026-07-28
2026-07-29
Lian BrianA · Grant / award
Acquired
Common Stock, par value $0.00001 per share221667.00.0
2026-07-28
2026-07-29
ZANTE GREGA · Grant / award
Acquired
Common Stock, par value $0.00001 per share31667.00.0
2026-07-28
2026-07-29
Mancini MariannaA · Grant / award
Acquired
Common Stock, par value $0.00001 per share31667.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001607678Viking Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$0$0
    2023-12-31$0$0
    2022-12-31$0$0
    2021-12-31$0$0
    2020-12-31$0$0
    2019-12-31$0$0
    2018-12-31$0$0
    2017-12-31$0$0

    Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

    Explore the CPI history ↗